Literature DB >> 24800931

Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?

Jayasree Pillarisetti1, Namratha Reddy, Mazda Biria, Kay Ryschon, Darbhamulla Nagarajan, Caroline Murray, Donita Atkins, Sudharani Bommana, Madhu Yeruva Reddy, Luigi DiBiase, Rhea Pimentel, Loren Berenbom, Buddhadeb Dawn, Andrea Natale, Dhanunjaya Lakkireddy.   

Abstract

BACKGROUND: Pre- and postablation atrial fibrillation (AF) brain natriuretic peptide (BNP) levels were shown to predict increased recurrence of AF following ablation.
OBJECTIVE: Our objective was to assess whether elevated BNP levels merely represent the presence of AF at the time of measurement or indeed the true recurrence of AF. METHODS AND
RESULTS: In a prospective study of 88 patients undergoing AF ablation, BNP levels were measured immediately before, after, 24 h, and 4-6 months postablation. BNP levels were stratified by presenting rhythm and ventricular rate at the time of measurement. Median BNP level preablation was higher in patients presenting in AF compared to sinus rhythm (SR) (54(44-79) pg/ml vs. 30(18-47) pg/ml, p < 0.001). Postablation restoration of SR in patients presenting in AF reduced median BNP levels from 54(44-79) pg/ml to 40(37-51) pg/ml, (p < 0.001). However, no change was noted in patients who presented in and maintained SR throughout the procedure (30(18-47) pg/ml to 27(16-40) pg/ml, p = 0.270). At 4-6 months, BNP measured in patients in SR was not significantly different from postablation BNP (35(22-53) pg/ml vs. 38(20-52) pg/ml, p = 0.656), although 35% of them had AF recurrence in 1-year follow-up. Median BNP level measured in five patients while in atrial arrhythmia was elevated compared to postablation BNP (464(421-464) pg/ml to 37(36-37) pg/ml, p = 0.043). BNP levels and ventricular rates are positively correlated at all times pre- and postablation.
CONCLUSIONS: BNP level rises acutely during AF and with rapid ventricular rates. BNP level seems to be a function of atrial rhythm and ventricular rate rather than short- or long-term predictor of AF ablation success.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24800931     DOI: 10.1007/s10840-014-9898-7

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  31 in total

1.  Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation.

Authors:  Takumi Yamada; Yoshimasa Murakami; Taro Okada; Naoki Yoshida; Junji Toyama; Yukihiko Yoshida; Naoya Tsuboi; Yasuya Inden; Makoto Hirai; Toyoaki Murohara
Journal:  Europace       Date:  2007-08-01       Impact factor: 5.214

Review 2.  B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities.

Authors:  Paul M McKie; John C Burnett
Journal:  Mayo Clin Proc       Date:  2005-08       Impact factor: 7.616

3.  Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation.

Authors:  Sanghamitra Mohanty; Prasant Mohanty; Luigi Di Biase; Bai Rong; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2011-03-03

4.  Catheter ablation for atrial fibrillation.

Authors:  P Jais; P Sanders; L F Hsu; M Hocini; M Haissaguerre
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

5.  B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation.

Authors:  Jingtian Li; Lexin Wang
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

6.  Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm.

Authors:  Luís Beck-da-Silva; Adolfo de Bold; Margaret Fraser; Kathryn Williams; Haissam Haddad
Journal:  Can J Cardiol       Date:  2004-10       Impact factor: 5.223

7.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

8.  Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues.

Authors:  A L Gerbes; L Dagnino; T Nguyen; M Nemer
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958

9.  Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm.

Authors:  Craig S Vinch; Jason Rashkin; Giridhar Logsetty; Dennis A Tighe; Jeffrey C Hill; Theo E Meyer; Lawrence S Rosenthal; Gerard P Aurigemma
Journal:  Cardiology       Date:  2004-09-22       Impact factor: 1.869

10.  Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.

Authors:  Hye Jin Hwang; Jung Woo Son; Byung-Ho Nam; Boyoung Joung; Byungho Lee; Jin-Bae Kim; Moon-Hyoung Lee; Yangsoo Jang; Namsik Chung; Won-Heum Shim; Seung-Yun Cho; Sung Soon Kim
Journal:  Clin Res Cardiol       Date:  2009-02-19       Impact factor: 5.460

View more
  6 in total

1.  Predictors of recurrence after pulmonary vein isolation in patients with normal left atrial diameter.

Authors:  Masamichi Yano; Yasuyuki Egami; Kyosuke Yanagawa; Yutaka Matsuhiro; Hitoshi Nakamura; Koji Yasumoto; Naotaka Okamoto; Akihiro Tanaka; Yasuharu Matsunaga-Lee; Daisuke Nakamura; Masaki Yamato; Ryu Shutta; Masami Nishino; Jun Tanouchi
Journal:  J Arrhythm       Date:  2019-09-02

2.  Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.

Authors:  Amir Y Shaikh; Nada Esa; William Martin-Doyle; Menhel Kinno; Iryna Nieto; Kevin C Floyd; Clifford Browning; Cynthia Ennis; J Kevin Donahue; Lawrence S Rosenthal; David D McManus
Journal:  Crit Pathw Cardiol       Date:  2015-12

3.  Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.

Authors:  Emmanouil Charitakis; Håkan Walfridsson; Urban Alehagen
Journal:  J Am Heart Assoc       Date:  2016-09-15       Impact factor: 5.501

4.  Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project.

Authors:  Hai Deng; Alena Shantsila; Pi Guo; Xianzhang Zhan; Xianhong Fang; Hongtao Liao; Yang Liu; Wei Wei; Lu Fu; Shulin Wu; Yumei Xue; Gregory Y H Lip
Journal:  J Arrhythm       Date:  2018-08-31

5.  Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved.

Authors:  Rasa Karaliūtė; Arnoldas Leleika; Ieva Apanavičiūtė; Tomas Kazakevičius; Vaida Mizarienė; Vytautas Zabiela; Aušra Kavoliūnienė; Nijolė Ragaišytė; Daiva Urbonienė; Gintarė Šakalytė
Journal:  Medicina (Kaunas)       Date:  2022-08-04       Impact factor: 2.948

6.  Clinical Significance of B-Type Natriuretic Peptide Levels at 3 Months after Atrial Fibrillation Ablation.

Authors:  Sen Matsumoto; Yasuharu Matsunaga-Lee; Masashi Ishimi; Mamoru Ohnishi; Nobutaka Masunaga; Koichi Tachibana; Yuzuru Takano
Journal:  Diseases       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.